Additional file 1: Figure S1. of Development of a surrogate potency assay to determine the angiogenic activity of StempeucelÂŽ, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell product
Charan Thej
Balamurugan Ramadasse
Ankita Walvekar
Anish Majumdar
Sudha Balasubramanian
10.6084/m9.figshare.c.3705505_D1.v1
https://springernature.figshare.com/articles/figure/Additional_file_1_Figure_S1_of_Development_of_a_surrogate_potency_assay_to_determine_the_angiogenic_activity_of_Stempeucel_a_pooled_ex-vivo_expanded_allogeneic_human_bone_marrow_mesenchymal_stromal_cell_product/4705666
showing a characterization of phBMMSCs for MSC-positive surface markers (CD44, CD73, CD90, CD105 and CD166) and negative markers (CD14, CD19, CD34, CD45, CD133 and HLA-DR), and indication of viability (inset), by flow cytometry; b differentiation of phBMMSCs into adipocytes, osteocytes and chondrocytes, stained with Oil Red O, Alizarin Red and Saffranin O, respectively. (TIF 6151Â kb)
2017-02-28 05:00:00
Potency assay
Angiogenesis
Pooled human bone marrow-derived mesenchymal stromal cell
Vascular endothelial growth factor
Endothelial tube formation